ePrints

Evaluation of the acceptability of a new oral vitamin K prophylaxis for breastfed infants

Lookup NU author(s): Dr Eugen-Matthias Strehle

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.

Abstract

Aim: The aim of this study was to investigate the acceptability and tolerability of the oral food supplement Neokay for the prevention of vitamin K deficiency bleeding in newborns. Methods: A questionnaire survey was conducted among 45 midwives in which they were asked 10 questions about their use of Neokay, its advantages and disadvantages, and their perceptions of parental attitudes towards this new prophylactic treatment. Results: During a 6-month period one dose of Neokay was given to 1794 healthy newborns at birth and further daily doses were given to 812 breastfed infants for 3 months. The midwives listed as main advantages ease of administration, no need for prescription or written consent, and transfer of responsibility to parents. As disadvantages, they mentioned possible reduced compliance as a result of the frequency of dosing, decreased parental confidence in breastfeeding and technical issues with packaging. Conclusion: A prophylactic vitamin K dosage regimen of 1 mg oral vitamin K (Konakion MM Paediatric or Orakay) given to all healthy neonates at birth, combined with daily doses of 50 mu g Neokay for 3 months for breastfed babies is well tolerated and acceptable to midwives and parents.

Publication metadata

Author(s): Strehle EM, Howey C, Jones R

Publication type: Article

Publication status: Published

Journal: Acta Paediatrica

Year: 2010

Volume: 99

Issue: 3

Pages: 379-383

ISSN (print): 0803-5253

ISSN (electronic): 1651-2227

Publisher: Wiley-Blackwell

URL: http://dx.doi.org/10.1111/j.1651-2227.2009.01630.x

DOI: 10.1111/j.1651-2227.2009.01630.x

PubMed id: 19958305

Altmetrics

Share